Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NONE | Class I Common Stock | Award | +1.6K | +23.01% | 8.54K | Oct 1, 2021 | Direct | F1 | ||
transaction | NONE | Class I Common Stock | Award | +15.4K | 15.4K | Oct 1, 2021 | By IRA | F1 | |||
transaction | NONE | Class T Common Stock | Award | $0 | +95.6K | +3672.15% | $0.00 | 98.2K | Oct 4, 2021 | Direct | F2 |
Id | Content |
---|---|
F1 | Reflects the acquisition of shares of the Issuer's common stock in connection with the merger (the "Merger") of Griffin-American Healthcare REIT III, Inc. ("GAHR III") with and into Continental Merger Sub, LLC, a wholly-owned subsidiary of American Healthcare REIT, Inc. ("AHR"). In the Merger, each share of GAHR III's common stock, par value $0.01 per share, was converted into the right to receive 0.9266 shares of the Issuer's Class I common stock, par value $0.01 per share ("AHR Class I Common Stock"). There is no established market for shares of AHR Class I Common Stock. On March 18, 2021, the board of directors of AHR approved an estimated value per share of AHR Class I Common Stock of $9.22. |
F2 | On October 4, 2021, the Reporting Person was granted (a) 26,437 shares of restricted Class T common stock which vest in three equal annual installments on October 1, 2022, October 1, 2023 and October 1,2024 (subject to continuous employment through each vesting date), and (b) 69,149 shares of restricted Class T common stock which vest on October 4, 2024 (subject to continuous employment through eachvesting date). |